Subcommittees

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, announced that Joel Miller has been named Deputy Staff Director, following the departure of Sophie Khanahmadi. Joel Miller—Deputy Staff Director Having served as the Committee’s Chief Counsel since the beginning of this Congress, Joel Miller will now serve as the Deputy Staff Director of the House Committee on Energy and Commerce. As Chief Counsel, Joel has played a central role in executing the Committee’s legislative priorities in the 119 th Congress, including the Working Families Tax Cuts reconciliation package. A former FCC Senior Legal Advisor and Chief of Staff, Joel also served previously as Chairman Guthrie’s Deputy Chief of Staff and Legislative Director.

WASHINGTON, D.C.  – This week, the House Committee on Energy and Commerce is holding four Subcommittee Hearings. Read more below.  SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Energy is holding a hearing to discuss the lessons learned from Winter Storm Fern. DATE:  Tuesday, March 17, 2026   TIME:  10:00 AM ET  LOCATION:  2123 Rayburn House Office Building  SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Oversight and Investigations is holding a hearing on what the Trump Administration is doing to proactively tackle Medicare and Medicaid fraud, as well as continuing conversations surrounding common fraud schemes and programs that are vulnerable to fraud. DATE:  Tuesday, March 17, 2026  TIME:  2:00 PM ET  LOCATION:  2123 Rayburn House Office Building  SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Health is holding a hearing on the role that providers play in making health care more affordable for all Americans.   DATE:  Wednesday, March 18, 2026  TIME:  10:15 AM ET  LOCATION:  2123 Rayburn House Office Building   SUBCOMMITTEE HEARING:  The Energy and Commerce Subcommittee on Communications and Technology is holding a hearing on the World Radiocommunication Conference.   DATE:  Wednesday, March 18, 2026  TIME:  2:00 PM ET  LOCATION:  2123 Rayburn House Office Building  ###

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement following Environmental Protection Agency (EPA) Administrator Zeldin’s announcement that the agency proposed amending a Biden-Harris Administration regulation that weaponized air emissions standards to halt the production and use of ethylene oxide (EtO) to sterilize medical equipment. “Today’s EPA announcement is a victory for commonsense policies that safeguard patients and put an end to the overreach of the Biden-Harris Administration,” said Chairman Guthrie. “ The burdensome ethylene oxide rule threatened to shutter sterilization facilities and disrupt American medical supply chains that hospitals and providers rely on every day to safely treat patients. By proposing an amendment to this misguided regulation, EPA Administrator Zeldin is working under the authority that Congress provided under the Clean Air Act to help ensure the medical community maintains access to a safe and reliable domestic supply of sterilized medical devices used in millions of procedures each year, while continuing to protect human health and the environment.”   BACKGROUND: Ethylene oxide (EtO) is used to sterilize approximately half of all medical devices sold in the United States, including surgical instruments, syringes, and implants. For many heat- and moisture-sensitive devices, there is currently no viable alternative sterilization method. The emission standards put in place by the Biden-Harris Administration threatens the ability for facilities to fully and safely sterilize essential medical equipment. In 2023, the Committee on Energy and Commerce, Subcommittee on Environment, Manufacturing, & Critical Materials held a hearing on the Biden-Harris Administration’s proposed rulemaking, where witnesses testified to how the proposal would significantly disrupt patient access to emergency care and threaten patient safety from hospital-born infections.